Back to search

Democritus University of Thrace (DUTH)

Η χορήγηση αλλοπουρινόλης ως αντιοξειδωτικού παράγοντα στην πρόληψη της μετα-αναστροφής ενδοσκοπικής χολαγγειο-παγκρεατογραφικής παγκρεατίτιτδας: κλινική μελέτη

Abstract

dc:description

Introduction and aims of study: Acute pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP), occuring in 1%-2% of patients undergoing the procedure in most large series (0 - 40% in smaller series). The majority of patients have a mild course, with rapid resolution of symptoms and no sequalae, but acute necrotizing pancreatitis, although uncommon, is well recognized. Most attempts to prevent post-ERCP pancreatitis have been disappointing. Recently, clinical applications of protease inhibitors such as gabexate have shown that medical therapy may be successful in reducing pancreatic complications after ERCP, although the high cost and complexity of administration of these drugs limit their widespread use. There is some evidence, based on experimental models, that allopurinol may reduce postprocedural rates of hyperamylasemia, edema of the pancreas and true post-ERCP pancreatitis. Allopurinol, a specific xanthine oxidase inhibitor, prevents the generation of oxygen-derived free radicals and is expected to block the early events in the cascade leading to pancreatic injury. The aim of this prospective study was to determine the effect of prophylactic use of oral allopurinol on the incidence of post-ERCP pancreatitis. Material and Methods: 250 patients were randomized to receive either 600 mg allopurinol orally (Group A) or placebo (Group B), 2h prior to ERCP. Pancreatitis was considered to be present when there was upper abdominal pain with tenderness, need for narcotics analgesia, serum amylase more than three times the upper normal limit and prolonged hospitalization (>24h). Sex, age, sphincterotomy, pre-cut technique, pancreatic duct visualization, acinarization, presence of nephrogram and hospitalization were tested for significance as risk factors using multivariate analysis. Results: 125 patients were included in Group A and 118 patients were included in Group B. The incidence of pancreatitis (17.8% vs. 3.2%, p<0.05) was higher in the placebo group than in the allopourinol-pretreated group. The overall incidence of pancreatitis was 10,29%. Multivariate analysis showed that i) “Hospitalization” was a significant risk factor in favor of allopourinol group (x2=27,10;p<0,001) meaning that patients who receive allopourinol have a statistically less significant risk for prolonged hospitalization and ii) . women of placebo group had a ten fold odds ratio to suffer from pancreatitis than men in the same group becoming equal when they received allopourinol. Conclusions: Pretreatment with oral allopurinol decreases the incidence of post-Ercp pancreatitis, the length of hospitalization and reduces the risk of women to suffer from post-ERCP pancreatitis.

Degree

thesis:*
Grantor dc:publisher
Democritus University of Thrace (DUTH)
Year dc:date
2004

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Chatzis, Iosif
  • Χατζής, Ιωσήφ

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/17463

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Chatzis, Iosif; Χατζής, Ιωσήφ. Η χορήγηση αλλοπουρινόλης ως αντιοξειδωτικού παράγοντα στην πρόληψη της μετα-αναστροφής ενδοσκοπικής χολαγγειο-παγκρεατογραφικής παγκρεατίτιτδας: κλινική μελέτη. Democritus University of Thrace (DUTH), 2004. http://hdl.handle.net/10442/hedi/17463